BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North
BBS-Bioactive Bone Substitutes Plc | Company Release | March 05, 2025 at 14:30:00 EET
The Board of Directors of BBS-Bioactive Bone Substitutes Plc ("BBS" or the "Company") resolved at its meeting on February 12, 2025, to file for bankruptcy. Subsequently, the Oulu District Court declared the Company bankrupt on February 17, 2025, at 1:00 PM (Decision Number: 25/4037, Case K 25/3957).
In light of this development, the Company has applied to delist its shares from the Nasdaq First North Growth Market, following applicable regulations. Once the company receives confirmation from Nasdaq First North, it will announce the final trading date for BBS shares in a separate press release.